Literature DB >> 7162302

Sudden hearing loss in the contralateral ear in postoperative acoustic tumor: three case reports.

J D Clemis, P G Mastricola, M Schuler-Vogler.   

Abstract

Careful presurgical otologic assessment of the contralateral ear in acoustic tumor patients is essential, not only to establish baseline data but more importantly to resolve the intense patient anxiety that arises almost immediately when the diagnosis is presented. Any subsequent reduction in hearing acuity in the contralateral ear after the tumor ear has been deafened, poses serious psychological, socio-economic and medical problems. Three detailed case reports of sudden hearing loss in the contralateral ear of postoperative acoustic tumor patients are presented. The lesion sites include: the middle ear, cochlear, and retrocochlear. In each case, hearing returned to its previous or near-previous levels. Allergic factors were implicated in two cases.

Entities:  

Mesh:

Year:  1982        PMID: 7162302     DOI: 10.1288/00005537-198201000-00017

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Sudden hearing loss and facial palsy at the contralateral side following acoustic tumour removal.

Authors:  J de Keyser; M Bruyland; P Demol; R Klaes; G Ebinger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-07       Impact factor: 10.154

2.  Contralateral hearing loss and facial palsy in an operated case of vestibular schwannoma-Case report.

Authors:  Abhijit Warade; Pawan Chawla; Anshu Warade; Ketan Desai
Journal:  Int J Surg Case Rep       Date:  2016-10-17

3. 

Authors:  C Cassandro; P De Luca; M Ralli; F Gioacchini; F Di Berardino; A Albera; R Albera; E Cassandro; A Scarpa
Journal:  Transl Med UniSa       Date:  2019-01-12

Review 4.  Progression of Contralateral Hearing Loss in Patients with Unilateral Ear Involvement: A Scoping Review.

Authors:  Marzieh Amiri; Mahdieh Hasanalifard; Fakher Rahim; Alimohamad Asghari; Golshan Mirmomeni; Arash Bayat
Journal:  J Int Adv Otol       Date:  2022-09       Impact factor: 1.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.